2024年活性胶原贴敷料研究报告

Investment Rating - The report does not explicitly state an investment rating for the collagen industry. Core Insights - The collagen market in China is experiencing unprecedented growth, driven by increasing consumer awareness of its health and beauty benefits, leading to sustained demand [63]. - The medical and aesthetic applications of collagen are expanding, with significant advancements in technology enhancing its effectiveness and safety [31][32][87]. - The report highlights the importance of regulatory approvals for collagen medical devices, indicating a growing market with stringent safety and efficacy requirements [41][66]. Summary by Sections Chapter 1: Overview of Collagen - Collagen is a key structural protein in multicellular organisms, constituting about 30% of total protein in the human body [2]. - Different types of collagen exist, each serving specific functions in various tissues, such as skin, bones, tendons, and cartilage [17]. - The extraction of collagen involves removing impurities from raw materials, which can include proteins, polysaccharides, fats, and minerals [12][23]. Chapter 2: Applications of Collagen - Collagen is widely used in the medical field for its mechanical properties, aiding in tissue repair and regeneration [31]. - In aesthetic medicine, modified collagen products are used for injections to improve skin quality and reduce wrinkles, with several products approved for dermal injection in China [33]. - Collagen's role in skincare products is significant, as it provides moisturizing and repairing benefits, leading to increased demand for functional skincare products [35][58]. Chapter 3: Market Analysis of Collagen - The collagen market in China is projected to grow significantly, with rising consumer acceptance of medical aesthetics and post-operative recovery products [64]. - As of November 2024, nearly a thousand collagen medical device products have been approved in China, indicating a robust regulatory environment [41]. - The report notes that the approval process for Class III medical devices is stringent, with only about 40 collagen products achieving this status, highlighting the challenges in the market [66].